Effect of Romosozumab Treatment in Postmenopausal Women With Osteoporosis and Knee Osteoarthritis: Results From a Substudy of a Phase 3 Clinical Trial

Effect of Romosozumab Treatment in Postmenopausal Women With Osteoporosis and Knee Osteoarthritis: Results From a Substudy of a Phase 3 Clinical Trial

Objective Romosozumab is a bone‐forming agent approved for osteoporosis treatment. Here we report results of the protocol‐specified, noninferiority osteoarthritis substudy of the fracture study in postmenopausal women with osteoporosis (FRAME), which evaluated the effect of romosozumab versus placeb...

Full description

Bibliographic Details
Main Authors:	Nancy E. Lane, Donald Betah, Cynthia Deignan, Mary Oates, Zhenxun Wang, Jen Timoshanko, Aliya A. Khan, Neil Binkley
Format:	Article
Language:	English
Published:	Wiley 2024-01-01
Series:	ACR Open Rheumatology
Online Access:	https://doi.org/10.1002/acr2.11619

Similar Items

Romosozumab for the treatment of osteoporosis
by: Michael R. McClung
Published: (2018-03-01)

Romosozumab in osteoporosis: yesterday, today and tomorrow
by: Dong Wu, et al.
Published: (2023-09-01)

The Relationship Between Knee Osteoarthritis and Osteoporosis in Postmenopausal Women
by: S. Karakaşlı, et al.
Published: (2002-06-01)

Profile of romosozumab and its potential in the management of osteoporosis
by: Lim SY, et al.
Published: (2017-04-01)

Glucocorticoid-Induced Osteoporosis: The Potential Role of Romosozumab
by: Jacqueline So, et al.
Published: (2020-12-01)

Romosozumab in Postmenopausal Korean Women with Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study
by: Ki-Hyun Baek, et al.
Published: (2021-02-01)

Vitiligo progression in a patient undergoing romosozumab treatment for osteoporosis
by: Nicole Trepanowski, MD, et al.
Published: (2023-12-01)

Effect of romosozumab in premenopausal women with severe osteoporosis and anorexia nervosa
by: Kazuki Fujimoto, et al.
Published: (2023-12-01)

Romosozumab for the treatment of osteoporosis in women: Efficacy, safety, and cardiovascular risk
by: Sian Yik Lim
Published: (2022-09-01)

Romosozumab versus Teriparatide for the Treatment of Postmenopausal Osteoporosis: A Systematic Review and Meta‐analysis through a Grade Analysis of Evidence
by: Aixian Tian, et al.
Published: (2021-10-01)

Clinical Utility of Romosozumab in the Management of Osteoporosis: Focus on Patient Selection and Perspectives
by: Lim SY, et al.
Published: (2022-12-01)

The effect of postmenopausal osteoporosis on subchondral bone pathology in a rat model of knee osteoarthritis
by: Hiroyuki Wada, et al.
Published: (2023-02-01)

Association of osteoporosis and varus inclination of the tibial plateau in postmenopausal women with advanced osteoarthritis of the knee
by: Shun-Ping Wang, et al.
Published: (2021-02-01)

Pregnancy and Lactation-Associated Osteoporosis Successfully Treated with Romosozumab: A Case Report
by: Yoichi Kaneuchi, et al.
Published: (2022-12-01)

Osteoporosis Improved by Romosozumab Therapy in a Patient With Type I Osteogenesis Imperfecta
by: Antara Dattagupta, MD, MEng, et al.
Published: (2023-11-01)

Osteoporosis clinical practice guideline: romosozumab for treating severe osteoporosis – an update by the Egyptian Academy of Bone Health
by: Yasser El Miedany, et al.
Published: (2022-09-01)

Osteoporosis is associated with varus deformity in postmenopausal women with knee osteoarthritis: a cross-sectional study
by: Cheng Zhang, et al.
Published: (2021-08-01)

The Effects of Switch Therapy in Osteoporosis Treatment after Romosozumab after Comparing with Prior Treatment
by: Akira Horikawa, et al.
Published: (2024-01-01)

Romosozumab and cardiovascular safety in Japan
by: Yasuhiro Takeuchi
Published: (2021-09-01)

Meta-analysis of the effects of denosumab and romosozumab on bone mineral density and turnover markers in patients with osteoporosis
by: Mingwei Hu, et al.
Published: (2023-07-01)

Romosozumab and blosozumab: alternative drugs of mechanical strain-related stimulus toward a cure for osteoporosis
by: Toshihiro eSugiyama, et al.
Published: (2015-04-01)

The Relationship Between Knee Osteoarthritis and Osteoporosis
by: Ilhan Sezer, et al.
Published: (2010-12-01)

Associations between clinical evidence of inflammation and synovitis in symptomatic knee osteoarthritis: A substudy of the VIDEO trial
by: Wallace, G, et al.
Published: (2016)

Risk of falls in postmenopausal women treated with romosozumab: Preliminary indices from a meta-analysis of randomized, controlled trials
by: Luis Möckel, et al.
Published: (2020-03-01)

Romosozumab-associated medication-related osteonecrosis of the jaw
by: Benjamin Palla, et al.
Published: (2023-06-01)

Factors associated with osteoporosis in postmenopausal women
by: Talma Reis Leal Fernandes, et al.
Published: (2015-11-01)

Zoledronic acid does not slow spinal radiographic progression of osteoarthritis in postmenopausal women with osteoporosis and radiographic osteoarthritis
by: L.V. Host, et al.
Published: (2022-03-01)

Impact of romosozumab on serum calcium concentration and factors predicting the fluctuations in calcium concentration upon romosozumab administration: A multicenter retrospective study
by: Hiroyuki Inose, et al.
Published: (2022-12-01)

Therapeutic Drug Review on Romosozumab: The First Sclerostin Inhibitor
by: Vijay Kumar Jain, et al.
Published: (2022-04-01)

BREASTFEEDING AND POSTMENOPAUSAL OSTEOPOROSIS
by: Horia Lăzărescu, et al.
Published: (2019-09-01)

Botanicals in Postmenopausal Osteoporosis
by: Wojciech Słupski, et al.
Published: (2021-05-01)

Hypercalciuria in Postmenopausal Osteoporosis
by: Ayfer Kanberoğlu, et al.
Published: (2004-06-01)

Osteoporosis in postmenopausal women
by: Harvey, M, et al.
Published: (2002)

Management of postmenopausal osteoporosis
by: Yeap SS, et al.
Published: (2013-10-01)

Romosozumab improves low bone mineral density in a postmenopausal woman undergoing chronic hemodialysis and treated with a calcium-sensing receptor agonist
by: Masatomo Ogata, et al.
Published: (2022-12-01)

Postmenopausal women with osteoarthritis and osteoporosis show different ultrastructural characteristics of trabecular bone of the femoral head
by: Jiang Lei-Sheng, et al.
Published: (2009-04-01)

Incidence of Secondary Hyperparathyroidism among Postmenopausal Women with End-Stage Knee Osteoarthritis
by: Kyriakos A Papavasiliou, et al.
Published: (2009-12-01)

Our Patients with Knee Osteoarthritis Risk Factors and Relationship with Osteoarhritis-Osteoporosis
by: Nadide Torlak Koca, et al.
Published: (2015-04-01)

Correlation of Femoral Cartilage Thickness and Osteoporosis in Female Patients with Knee Osteoarthritis
by: Gamze Altuğ Özövez, et al.
Published: (2021-08-01)

Effect of Weekly Alendronate on Knee Symptoms in Patients with Osteoporosis and Knee Osteoarthritis Coexistence - Original Investigation
by: Levent Ediz, et al.
Published: (2010-04-01)